ADIAL PHARMACEUTICALS, INC. cotiza a 3.50 USD y tiene una capitalización bursátil de $9M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disor…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-1.48 | $-11.48 | $-2.00 | $-4.50 |
| Estimado | $-2.25 | $-2.13 | $-3.50 | $-5.50 |
| Sorpresa | +34.2% | -439.0% | +42.9% | +18.2% |
| Métrica | ADIL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -151.2% | -40.4% | -110.8% |
| ROA | -119.5% | -32.0% | -87.5% |
| Current Ratio | 4.42 | 2.84 | +1.58 |
| Debt / Equity | — | 0.28 | — |